Focalyx

Focalyx is a private urology-focused medtech company developing and commercializing precision tools and care pathways for prostate cancer diagnosis and treatment. Its core product is Focalyx Fusion, an FDA-cleared software as a medical device that uses MRI/ultrasound image fusion for computer-assisted planning and real-time guidance during minimally invasive prostate procedures. The company also markets the broader Focalyx treatment methodology, which is designed to identify and ablate cancerous prostate lesions while preserving healthy tissue and quality of life. Focalyx appears to operate as a provider-facing medical device and software business with associated patient-facing prostate cancer treatment services. The company is positioned in men's health and urologic oncology rather than traditional drug development.